OCULIS HOLDING AG OCS
ORDINARY SHARES · Common Stock · CUSIP H5870P102
- SectorHealth care
- IndustryPharmaceutical Preparations
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once ($9.8m this quarter). Holder counts are more reliable. Implied quarter-end price ≈ $19.03.
Trends to Q1 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q1 2023 | 7 |
| Q2 2023 | 10 |
| Q3 2023 | 10 |
| Q4 2023 | 8 |
| Q1 2024 | 10 |
| Q2 2024 | 12 |
| Q3 2024 | 11 |
| Q4 2024 | 13 |
| Q1 2025 | 21 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q2 2023 | 4 | 2 |
| Q3 2023 | 4 | 4 |
| Q4 2023 | 4 | 6 |
| Q1 2024 | 4 | 4 |
| Q2 2024 | 3 | 2 |
| Q3 2024 | 3 | 3 |
| Q4 2024 | 8 | 1 |
| Q1 2025 | 18 | 3 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q2 2024 | $597.5k | $0 | 0.00 |
| Q3 2024 | $0 | $0 | — |
| Q4 2024 | $0 | $0 | — |
| Q1 2025 | $0 | $0 | — |
Biggest buyers
| Pivotal bioVenture Partners Investment Advisor LLC | Added | +563.1k |
| SR One Capital Management, LP | New | +322.5k |
| Aberdeen Group plc | Added | +243.7k |
| Alyeska Investment Group, L.P. | New | +131.3k |
| ACUTA CAPITAL PARTNERS, LLC | New | +125.0k |
| Nan Fung Group Holdings Ltd | Added | +78.3k |
| KESTRA PRIVATE WEALTH SERVICES, LLC | New | +12.3k |
| STATE STREET CORP | New | +12.0k |
| BANK OF AMERICA CORP /DE/ | Added | +10.7k |
| NORTHERN TRUST CORP | Added | +10.3k |
Biggest sellers
| CITADEL ADVISORS LLC | Sold out | -22.9k |
| XTX Topco Ltd | Sold out | -13.2k |
| Compagnie Lombard Odier SCmA | Reduced | -8.8k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| LSP 7 Cooperative UA 13G · exempt (held before listing) -2.0 pts · filed 2026-04-29 | 11.8% |
Fell to 5% or below in the last year: BVCF IV, L.P. (4.1%, 2026-03-27)
Insider purchases and sales in Q1 2025
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q1 2025.
Holders, Q1 2025
| Manager | Shares | Change |
|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC 35.43% of their portfolio | 2.3m $43.8m | Added +563.1k |
| Aberdeen Group plc 0.05% of their portfolio | 1.3m $23.8m | Added +243.7k |
| Nan Fung Group Holdings Ltd 7.99% of their portfolio | 514.7k $9.8m | Added +78.3k |
| SR One Capital Management, LP 1.58% of their portfolio | 322.5k $6.1m | New |
| Alyeska Investment Group, L.P. 0.01% of their portfolio | 131.3k $2.5m | New |
| ACUTA CAPITAL PARTNERS, LLC 2.76% of their portfolio | 125.0k $2.4m | New |
| UBS Group AG 0.00% of their portfolio | 113.0k $2.1m | Added +4.1k |
| Compagnie Lombard Odier SCmA 0.02% of their portfolio | 87.0k $1.7m | Reduced -8.8k |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 39.6k $754.2k | Added +10.7k |
| NORTHERN TRUST CORP 0.00% of their portfolio | 23.8k $453.5k | Added +10.3k |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 23.1k $438.7k | Added +6.3k |
| Bellevue Group AG 0.01% of their portfolio | 14.1k $268.3k | Added +4.1k |
| KESTRA PRIVATE WEALTH SERVICES, LLC 0.00% of their portfolio | 12.3k $234.5k | New |
| STATE STREET CORP 0.00% of their portfolio | 12.0k $227.6k | New |
| MORGAN STANLEY 0.00% of their portfolio | 5.1k $97.4k | New |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 600 $11.4k | New |
| WOLVERINE ASSET MANAGEMENT LLC 0.00% of their portfolio | 399 $7.6k | New |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 26 $495 | New |
| DUPONT CAPITAL MANAGEMENT CORP 0.00% of their portfolio | 4 $76 | Unchanged |
| SBI Securities Co., Ltd. 0.00% of their portfolio | 4 $76 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. — of their portfolio | 0 $0 | Unchanged |